Wenxin Li Selected Research

Wenxin Li Research Topics

Disease

43	Neoplasms (Cancer) 03/2024 - 02/2002
13	Infections 10/2023 - 01/2011
10	Carcinogenesis 11/2023 - 12/2012
10	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 07/2017
9	Neoplasm Metastasis (Metastasis) 02/2024 - 07/2011
8	Inflammation (Inflammations) 03/2024 - 11/2018
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2015
6	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 02/2011
5	Virus Diseases (Viral Diseases) 12/2019 - 09/2015
4	Body Weight (Weight, Body) 02/2024 - 09/2020
3	Esophageal Squamous Cell Carcinoma 02/2024 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2023
3	COVID-19 10/2023 - 04/2021
3	Disease Progression 09/2023 - 01/2022
3	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2021
3	Chronic Renal Insufficiency 01/2022 - 12/2018
3	Channelopathies 01/2018 - 01/2011
3	Glioma (Gliomas) 02/2016 - 05/2010
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015 - 12/2012
3	Bacterial Infections (Bacterial Infection) 08/2012 - 11/2008
3	Parkinson Disease (Parkinson's Disease) 12/2008 - 01/2005
2	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2017
2	Rectal Neoplasms (Rectal Cancer) 01/2024 - 12/2023
2	Constipation 05/2023 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 03/2023 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2020 - 02/2015
2	Lung Neoplasms (Lung Cancer) 07/2020 - 07/2011
2	Pain (Aches) 01/2020 - 01/2019
2	Hypersensitivity (Allergy) 01/2019 - 03/2017
2	Hypoxia (Hypoxemia) 01/2018 - 06/2015
2	Leukemia 01/2015 - 01/2013
2	Gigantism 06/2014 - 08/2013
2	Acromegaly 06/2014 - 08/2013
2	Carcinoid Tumor (Carcinoid) 06/2014 - 08/2013
2	Measles 01/2012 - 07/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2010 - 12/2008
2	Epilepsy (Aura) 01/2005 - 12/2003
1	Gallbladder Neoplasms (Gallbladder Cancer) 05/2024
1	Gallbladder Diseases (Gall Bladder Disease) 05/2024
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2024
1	Extranodal NK-T-Cell Lymphoma 03/2024
1	Lymphoma (Lymphomas) 03/2024
1	Weight Loss (Weight Reduction) 02/2024

Drug/Important Bio-Agent (IBA)

19	Peptides (Polypeptides)IBA 01/2023 - 02/2007
12	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2011
11	Scorpion Venoms (Scorpion Venom)IBA 11/2022 - 01/2011
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
5	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2011
5	Antiviral Agents (Antivirals)IBA 01/2020 - 07/2011
4	Messenger RNA (mRNA)IBA 12/2023 - 09/2006
4	CytokinesIBA 01/2022 - 07/2017
4	Small Interfering RNA (siRNA)IBA 05/2021 - 07/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2002
4	DefensinsIBA 01/2021 - 12/2017
4	Protein Isoforms (Isoforms)IBA 10/2013 - 09/2006
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024 - 01/2023
3	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2013
3	Circular RNAIBA 01/2024 - 01/2019
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 06/2015
3	Potassium Channels (Potassium Channel)IBA 11/2020 - 02/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 11/2011
3	Ion Channels (Ion Channel)IBA 01/2018 - 01/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 01/2023
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2024 - 01/2023
2	Long Noncoding RNAIBA 10/2023 - 01/2018
2	Loperamide (Imodium)FDA LinkGeneric 05/2023 - 01/2023
2	APTIBA 01/2023 - 05/2021
2	Immunologic Factors (Immunomodulators)IBA 01/2023 - 04/2016
2	IronIBA 01/2023 - 01/2018
2	CarbonIBA 01/2023 - 01/2019
2	Chymotrypsin FDA Link 11/2022 - 04/2014
2	CalciumIBA 01/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 10/2021 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2019
2	VenomsIBA 01/2020 - 02/2014
2	VaccinesIBA 01/2020 - 01/2019
2	Interleukin-2 (IL2)IBA 01/2019 - 02/2015
2	Interferon Type IIBA 12/2018 - 07/2017
2	InterferonsIBA 12/2018 - 01/2016
2	PotassiumIBA 01/2017 - 01/2013
2	Chloride Channels (Chloride Channel)IBA 02/2016 - 05/2010
2	ChlorotoxinIBA 02/2016 - 11/2010
2	Growth Hormone (Somatotropin)IBA 06/2014 - 08/2013
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2014 - 08/2013
2	NeurotoxinsIBA 11/2010 - 12/2003
2	hydroxide ionIBA 02/2010 - 12/2008
2	FullerenesIBA 02/2010 - 12/2008
2	gamma-Aminobutyric Acid (GABA)IBA 02/2008 - 10/2007
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 02/2008 - 01/2005
1	olfactomedinIBA 05/2024
1	StaurosporineIBA 03/2024
1	Liraglutide FDA Link 02/2024
1	Glucagon-Like Peptide-1 ReceptorIBA 02/2024

Therapy/Procedure

22	Therapeutics 02/2024 - 12/2003
4	Radiotherapy 03/2024 - 02/2007
3	Immunotherapy 01/2023 - 01/2021
2	Neoadjuvant Therapy 01/2024 - 12/2023
2	Drug Therapy (Chemotherapy) 12/2023 - 12/2015
2	Chemoradiotherapy 07/2021 - 01/2019
2	Intravenous Injections 03/2016 - 08/2012